Allurion Technologies 株価情報 (NYSE: ALUR)

Allurion Technologies (NYSE:ALUR) 株価情報

Allurion Technologies

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Allurion Technologies Inc

Allurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 1.420455 shares of common stock at an exercise price of $8.10 per share of common stock

Whales with a lot of money to spend have taken a noticeably bearish stance on Rivian Automotive.
Looking at options history for Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 58% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $306,236 and 8, calls, for a total amount of $573,379.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $7.5 to $32.0 for Rivian Automotive during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Rivian Automotive's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Rivian Automotive's substantial trades, within a strike price spectrum from $7.5 to $32.0 over the preceding 30 days.
<h3>Rivian Automotive Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743441337_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$5.6</td>
<td>$5.3</td>
<td>$5.5</td>
<td>$10.00</td>
<td>$275.0K</td>
<td>4.2K</td>
<td>708</td>
</tr>
<tr>
<td>RIVN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$0.79</td>
<td>$0.76</td>
<td>$0.77</td>
<td>$7.50</td>
<td>$223.3K</td>
<td>73.9K</td>
<td>2.9K</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$1.48</td>
<td>$1.29</td>
<td>$1.35</td>
<td>$32.00</td>
<td>$80.8K</td>
<td>2.9K</td>
<td>2.0K</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$1.35</td>
<td>$1.27</td>
<td>$1.35</td>
<td>$32.00</td>
<td>$54.1K</td>
<td>2.9K</td>
<td>1.4K</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$2.97</td>
<td>$2.93</td>
<td>$2.93</td>
<td>$12.50</td>
<td>$38.0K</td>
<td>8.4K</td>
<td>148</td>
</tr>
</tbody>
</table>

<h3>About Rivian Automotive</h3>
Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues primarily from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.
In light of the recent options history for Rivian Automotive, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Rivian Automotive Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 18,083,864, with RIVN's price down by -1.21%, positioned at $12.26.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 36 days.</li>
</ul>
<h3>Expert Opinions on Rivian Automotive</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $14.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on Rivian Automotive with a target price of $11. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Neutral with a new price target of $13. 
&#x2A; An analyst from Benchmark downgraded its action to Buy with a price target of $18. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Rivian Automotive, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

RIVN

Looking At Rivian Automotive's Recent Unusual Options Activity

Financial giants have made a conspicuous bullish move on American Express. Our analysis of options history for American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) revealed 13 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $633,220, and 6 were calls, valued at $774,379.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $195.0 to $300.0 for American Express during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for American Express options trades today is 503.57 with a total volume of 1,855.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for American Express's big money trades within a strike price range of $195.0 to $300.0 over the last 30 days.
<h3>American Express Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743441332_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AXP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$33.0</td>
<td>$33.0</td>
<td>$33.0</td>
<td>$250.00</td>
<td>$240.9K</td>
<td align="right">752</td>
<td align="right">73</td>
</tr>
<tr>
<td>AXP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$33.1</td>
<td>$33.05</td>
<td>$33.1</td>
<td>$250.00</td>
<td>$201.9K</td>
<td align="right">752</td>
<td align="right">196</td>
</tr>
<tr>
<td>AXP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$28.95</td>
<td>$28.6</td>
<td>$28.95</td>
<td>$280.00</td>
<td>$188.1K</td>
<td align="right">949</td>
<td align="right">1</td>
</tr>
<tr>
<td>AXP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$31.35</td>
<td>$28.4</td>
<td>$29.5</td>
<td>$290.00</td>
<td>$162.2K</td>
<td align="right">222</td>
<td align="right">0</td>
</tr>
<tr>
<td>AXP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$10.5</td>
<td>$10.1</td>
<td>$10.1</td>
<td>$265.00</td>
<td>$145.4K</td>
<td align="right">461</td>
<td align="right">144</td>
</tr>
</tbody>
</table>

<h3>About American Express</h3>
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. Since 2018, it has operated in three segments: global consumer services, global commercial services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
Having examined the options trading patterns of American Express, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of American Express</h3>
<ul>
<li>Currently trading with a volume of 1,331,002, the AXP's price is up by 0.12%, now at $265.81. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 17 days.</li>
</ul>
<h3>Professional Analyst Ratings for American Express</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $305.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for American Express, targeting a price of $325. 
&#x2A; An analyst from Baird upgraded its action to Neutral with a price target of $265. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on American Express, maintaining a target price of $300. 
&#x2A; Consistent in their evaluation, an analyst from Goldman Sachs keeps a Buy rating on American Express with a target price of $330. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for American Express with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Unpacking the Latest Options Trading Trends in American Express

High-rolling investors have positioned themselves bullish on IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in IREN often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for IREN. This is not a typical pattern.
The sentiment among these major traders is split, with 62% bullish and 25% bearish. Among all the options we identified, there was one put, amounting to $52,000, and 7 calls, totaling $382,013.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.0 to $14.0 for IREN over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for IREN's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across IREN's significant trades, within a strike price range of $5.0 to $14.0, over the past month.
<h3>IREN Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743441327_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$2.27</td>
<td>$2.03</td>
<td>$2.27</td>
<td>$5.00</td>
<td>$104.4K</td>
<td>797</td>
<td>631</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.44</td>
<td>$1.43</td>
<td>$1.43</td>
<td>$7.50</td>
<td>$71.6K</td>
<td>14.2K</td>
<td>1.2K</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.4</td>
<td>$1.36</td>
<td>$1.4</td>
<td>$7.50</td>
<td>$56.0K</td>
<td>14.2K</td>
<td>1.8K</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.62</td>
<td>$2.5</td>
<td>$2.6</td>
<td>$8.00</td>
<td>$52.0K</td>
<td>1.0K</td>
<td>200</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$1.27</td>
<td>$1.2</td>
<td>$1.2</td>
<td>$8.00</td>
<td>$48.0K</td>
<td>1.1K</td>
<td>400</td>
</tr>
</tbody>
</table>

<h3>About IREN</h3>
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.
<h3>Present Market Standing of IREN</h3>
<ul>
<li>Currently trading with a volume of 7,058,764, the IREN's price is up by 0.41%, now at $6.09. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 44 days.</li>
</ul>
<h3>Expert Opinions on IREN</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $12.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Showing optimism, an analyst from JP Morgan upgrades its rating to Overweight with a revised price target of $12. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for IREN with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

IREN

Market Whales and Their Recent Bets on IREN Options

<ul>
<li>More than 92% of schizophrenia patients taking TEV-'749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication1</li>
<li>New data from UZEDY&#xAE; (risperidone) evaluated predictors of response in schizophrenia with efficacy observed across patient demographic and clinical characteristics in the Phase 3 RISE trial</li>
<li>Teva continues its commitment to generating clinical insights that help advance and support optimal treatment for individuals living with schizophrenia</li>
</ul>

Biotech

News

General

TEVA

Teva Highlights Phase 3 SOLARIS Trial Survey Results

WIIM

Oil is trading higher following President Trump's threats to impose tariffs on Russia's oil exports and warnings of military action against Iran. Additionally, U.S. crude oil production fell by 305,000 barrels per day to 13.15 million bpd in January, the lowest level since February 2024.

<h3>Gainers</h3>
<ul>
<li>AirNet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTE#NASDAQ">ANTE</a>) stock rose 18.7% to $0.46 during Monday's regular session. The company's market cap stands at $6.5 million. </li>
<li>Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) shares moved upwards by 14.52% to $2.05. The market value of their outstanding shares is at $41.8 million. As per the news, the Q4 earnings report came out 4 days ago. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) stock increased by 12.59% to $0.59. The company's market cap stands at $5.8 million. </li>
<li>Reading Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDI#NASDAQ">RDI</a>) shares increased by 10.39% to $1.38. The company's market cap stands at $30.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares rose 9.99% to $0.09. The market value of their outstanding shares is at $4.6 million. </li>
<li>Star Fashion Culture (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STFS#NASDAQ">STFS</a>) stock moved upwards by 8.37% to $1.02. The company's market cap stands at $12.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TEN Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHLD#NASDAQ">XHLD</a>) shares declined by 20.8% to $0.99 during Monday's regular session. The company's market cap stands at $27.9 million. </li>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) shares decreased by 17.57% to $0.6. The market value of their outstanding shares is at $10.4 million. As per the news, the Q4 earnings report came out 2 days ago. </li>
<li>Global Mofy AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares decreased by 16.39% to $3.25. The market value of their outstanding shares is at $9.5 million. </li>
<li>Snail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAL#NASDAQ">SNAL</a>) shares declined by 15.37% to $0.88. The market value of their outstanding shares is at $32.5 million. The company's, Q4 earnings came out 3 days ago. </li>
<li>trivago (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVG#NASDAQ">TRVG</a>) stock decreased by 12.06% to $4.16. The company's market cap stands at $290.9 million. </li>
<li>LZ Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) shares fell 11.87% to $7.5. The company's market cap stands at $1.1 billion. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ANTE

DRCT

LZMH

MITQ

SNAL

STFS

SURG

TRVG

XHLD

12 Communication Services Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) stock moved upwards by 88.8% to $103.12 during Monday's regular session. The market value of their outstanding shares is at $10.8 billion. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock increased by 38.2% to $35.48. The company's market cap stands at $461.6 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) shares rose 34.34% to $0.89. The market value of their outstanding shares is at $63.9 million. </li>
<li>bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) shares rose 26.41% to $5.16. The market value of their outstanding shares is at $50.2 million. The company's, Q4 earnings came out 2 days ago. </li>
<li>WORK Medical Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOK#NASDAQ">WOK</a>) shares moved upwards by 13.95% to $0.57. The company's market cap stands at $8.3 million. </li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock rose 13.34% to $0.97. The market value of their outstanding shares is at $23.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vaxcyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCVX#NASDAQ">PCVX</a>) shares declined by 46.9% to $36.92 during Monday's regular session. The company's market cap stands at $4.7 billion. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) shares fell 34.87% to $0.99. The market value of their outstanding shares is at $11.3 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) stock declined by 30.87% to $0.65. The company's market cap stands at $3.4 million. </li>
<li>Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) shares fell 30.06% to $1.35. The market value of their outstanding shares is at $276.7 million. </li>
<li>Polyrizon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) shares declined by 27.49% to $0.35. The market value of their outstanding shares is at $1.5 million. </li>
<li>Neurogene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) shares decreased by 23.08% to $11.17. The market value of their outstanding shares is at $166.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABVC

BLUE

CORT

CTOR

NGNE

NIVF

PCVX

PLRZ

TSHA

12 Health Care Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares increased by 27.7% to $0.27 during Monday's regular session. The company's market cap stands at $53.9 million. As per the press release, Q4 earnings came out today. </li>
<li>Huachen AI Parking Mgmt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAI#NASDAQ">HCAI</a>) shares rose 23.36% to $7.9. The market value of their outstanding shares is at $250.4 million. </li>
<li>FTC Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTCI#NASDAQ">FTCI</a>) stock rose 21.6% to $3.04. The market value of their outstanding shares is at $39.0 million. The company's, Q4 earnings came out today. </li>
<li>Decent Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXST#NASDAQ">DXST</a>) shares moved upwards by 11.96% to $1.2. The market value of their outstanding shares is at $19.4 million. </li>
<li>Toppoint Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOPP#AMEX">TOPP</a>) shares moved upwards by 9.09% to $1.44. The market value of their outstanding shares is at $25.2 million. </li>
<li>FBS Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBGL#NASDAQ">FBGL</a>) stock moved upwards by 8.13% to $0.93. The market value of their outstanding shares is at $12.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Safe Pro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPAI#NASDAQ">SPAI</a>) stock fell 17.1% to $2.2 during Monday's regular session. The market value of their outstanding shares is at $30.2 million. </li>
<li>Surf Air Mobility (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRFM#NYSE">SRFM</a>) stock fell 15.92% to $2.8. The company's market cap stands at $47.4 million. </li>
<li>Frontier Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULCC#NASDAQ">ULCC</a>) stock fell 14.59% to $4.1. The company's market cap stands at $931.7 million. </li>
<li>SUNation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SUNE#NASDAQ">SUNE</a>) shares decreased by 13.44% to $0.35. </li>
<li>Xos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOS#NASDAQ">XOS</a>) stock declined by 12.8% to $3.0. The company's market cap stands at $24.0 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>DSS (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DSS#AMEX">DSS</a>) shares declined by 12.14% to $0.88. The market value of their outstanding shares is at $7.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DXST

FBGL

FTCI

HCAI

LNZA

SPAI

SRFM

SUNE

TOPP

ULCC

12 Industrials Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares increased by 47.8% to $25.65 during Monday's regular session. The company's market cap stands at $255.7 million. </li>
<li>Foxx Development Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXX#NASDAQ">FOXX</a>) shares rose 24.77% to $5.44. The market value of their outstanding shares is at $39.6 million. </li>
<li>BK Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) shares rose 19.25% to $42.93. The market value of their outstanding shares is at $152.9 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) stock rose 10.61% to $2.87. The company's market cap stands at $445.7 million. </li>
<li>United Microelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UMC#NYSE">UMC</a>) shares increased by 10.45% to $7.24. The market value of their outstanding shares is at $18.1 billion. </li>
<li>Roadzen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDZN#NASDAQ">RDZN</a>) shares rose 9.79% to $1.06. The market value of their outstanding shares is at $78.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>AuthID (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) stock decreased by 27.5% to $4.7 during Monday's regular session. The market value of their outstanding shares is at $51.3 million. </li>
<li>Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) stock declined by 23.22% to $1.77. The market value of their outstanding shares is at $179.9 million. The company's, Q4 earnings came out 2 days ago. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) shares fell 23.0% to $0.69. The company's market cap stands at $7.3 million. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) shares fell 22.21% to $0.03. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) shares fell 16.2% to $1.5. The company's market cap stands at $1.8 million. </li>
<li>Maris Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEK#NASDAQ">MTEK</a>) stock declined by 14.35% to $2.21. The market value of their outstanding shares is at $17.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AUID

BKTI

BZAI

DGLY

FOXX

MLGO

MTEK

MYSZ

RDZN

SLNH

WOLF

12 Information Technology Stocks Moving In Monday's Intraday Session

Circle Internet Financial, the company behind the (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) stablecoin, is reviving its public listing ambitions and is reportedly preparing to file for an <a href="https://www.benzinga.com/money/what-does-ipo-mean">initial public offering</a> by late April.
What Happened: The crypto-focused fintech is working with JPMorgan Chase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NASDAQ">JPM</a>) and Citi as advisors, Fortune <a href="https://fortune.com/2025/03/31/circle-jpmorgan-chase-crypto-usdc-citi-ipos-spac-sec/">reported</a> on Monday, quoting sources familiar with the matter.
This would mark Circle's second major attempt to go public. 
Its earlier 2021 effort via a SPAC deal was abandoned after regulatory delays and broader market turmoil following the <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35445270/the-true-cost-of-the-ftx-collapse-how-much-did-sam-bankman-fried-really-make">collapse of crypto exchange</a> FTX.
In January 2024, Circle confidentially filed with the SEC for a traditional IPO, and the upcoming public filing will provide the first official look at the company's financials.
Founded in 2013 by Jeremy Allaire and Sean Neville, Circle has evolved from a broader crypto services firm into a stablecoin-focused financial platform. 
Its USDC stablecoin, once operated through a consortium called Centre with Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) as its sole remaining partner, has seen a dramatic rebound since early 2023. 
Following a brief de-pegging during the Silicon Valley Bank crisis—when $3.3 billion in reserves were temporarily locked—USDC has since recovered, now boasting a $60 billion market cap.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44564969/tom-lee-says-weve-got-the-right-pieces-for-a-bottom-bitcoin-could-do-well-into-year-end">Tom Lee Says &#8216;We&#8217;ve Got The Right Pieces For A Bottom,&#8217; Bitcoin &#8216;Could Do Well Into Year-End&#8217;</a>
Despite its growth, Circle's financial health remains closely tied to interest income. As of the first half of 2023, 99% of its revenue came from interest earned on reserve assets like U.S. Treasuries. 
Circle is reportedly seeking a valuation between $4 billion and $5 billion for its IPO, a sharp drop from the $9 billion valuation it reached during its SPAC attempt.
Why It Matters: Circle's public debut would be the largest crypto IPO since Coinbase went public in 2021.
Like Coinbase, Circle's IPO is arriving as the market for new listings shows renewed signs of life. 
So far in 2025, IPO activity has jumped 70% compared to the same period last year, signaling a more favorable climate for tech and crypto companies.
With stablecoin regulation advancing in Washington—backed by a pro-crypto stance from President Trump—Circle&#8217;s positioning in the market appears timely. 
However, the company now faces increased competition from both crypto-native firms and traditional finance players like PayPal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NYSE">PYPL</a>) and Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), which have launched stablecoins of their own.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44560290/trump-family-to-dive-into-bitcoin-mining-after-defi-meme-coin-projects">Trump Family To Dive Into Bitcoin Mining After DeFi, Meme Coin Projects</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$USDC

$XRP

COIN

PYPL

Circle Eyes $5 Billion Valuation For Upcoming Initial Public Offering

Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) is dialing up a bullish breakout as its stock pushes past key technical levels. With shares up 12.76% year to date and 5.20% in the past month, Verizon stock has now confirmed <a href="https://www.benzinga.com/topic/golden-cross">a golden cross</a>, a classic bullish indicator signaling potential for more upside.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0331"><img loading="lazy" decoding="async" width="631" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31115944/Screenshot-2025-03-31-at-6.32.44-PM.png" alt="" class="wp-image-849608" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31115944/Screenshot-2025-03-31-at-6.32.44-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31115944/Screenshot-2025-03-31-at-6.32.44-PM-300x232.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0331">Chart created using Benzinga Pro</a>
Read Also: <a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44420961/exclusive-why-defiance-etf-ceo-sees-big-gains-ahead-during-nvidias-6g-revolution" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Why Defiance ETF CEO Sees Big Gains Ahead During Nvidia&#8217;s 6G Revolution</a>
<h1 class="wp-block-heading">Verizon Stock Technicals Confirm A Strong Uptrend</h1>
At $44.93, Verizon stock is currently above its eight-day simple moving average (SMA) of $44.10, its 20-day SMA of $44.02, and its 50-day SMA of $42.04 — each flashing a bullish signal.
Even more significantly, Verizon stock's 50-day SMA has crossed above its 200-day SMA of $41.73, officially forming a golden cross.
The Moving Average Convergence Divergence (MACD) indicator stands at 0.60, reinforcing the bullish momentum, while the Relative Strength Index (RSI) at 60.70 suggests the stock is gaining strength but has not yet reached overbought territory. 
Selling pressure persists, which could pose risks if momentum stalls.
<h1 class="wp-block-heading">Investor Takeaway: Bullish Setup, But Watch For Resistance</h1>
Verizon's golden cross could attract technical traders looking to ride the trend, but some caution is warranted. The stock is experiencing selling pressure, which could lead to short-term volatility. 
If Verizon stock holds above key support levels, the uptrend could continue, making it a compelling opportunity for bullish investors.
With telecom stocks gaining renewed interest, all eyes are on whether Verizon can capitalize on its bullish setup or if resistance levels will put the brakes on its rally.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44560485/goldman-sachs-slashes-sp-500-price-outlook-as-tariffs-weaker-growth-hit-earnings">Goldman Sachs Slashes S&amp;P 500 Price Outlook As Tariffs, Weaker Growth Hit Earnings</a></li>
</ul>
Photo: Shutterstock

Technicals

Signals

Tech

Trading Ideas

Verizon Stock Flashes Bullish Signal As Golden Cross Confirms Uptrend

Rocket Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>) announced on Monday an all-stock acquisition of Mr. Cooper Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44558087/mr-cooper-americas-largest-servicer-joins-rocket-the-nations-largest-lender" rel="noreferrer noopener">in a deal valued at $9.4 billion.</a>
Under the terms of the agreement, Mr. Cooper shareholders will receive 11.0 Rocket shares for each Mr. Cooper share, valuing the deal at $143.33 per share, a 35% premium over the stock&#8217;s 30-day volume-weighted average.
The deal is structured as a tax-free transaction for Mr. Cooper shareholders and includes a $2.00 per share dividend before closing.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/03/44558573/president-trumps-sons-partner-with-hut-8-to-unveil-american-bitcoin-for-large-scale-bitcoin-mining" rel="noreferrer noopener">President Trump&#8217;s Sons Partner With Hut 8 To Unveil American Bitcoin For Large-Scale Bitcoin Mining</a>
With this acquisition, Rocket Companies will substantially grow its mortgage servicing portfolio to exceed $2.1 trillion, encompassing almost 10 million clients. This expansion accounts for roughly one in six mortgages across the U.S.
Rocket&#8217;s acquisition of Mr. Cooper follows its recent agreement to acquire <a target="_blank" href="https://www.benzinga.com/news/25/03/44218758/rocket-wants-1-75-billion-redfin-deal-to-change-how-america-buys-homes" rel="noreferrer noopener">digital brokerage platform</a> Redfin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>), furthering its goal of streamlining the homeownership experience.
By integrating Mr. Cooper&#8217;s servicing expertise with Rocket&#8217;s customer acquisition strategies, the company expects to generate $500 million in annual revenue and cost synergies.
By acquiring Mr. Cooper, Rocket will gain valuable insights from nearly 7 million additional clients and 150 million yearly customer interactions. The company intends to use this extensive dataset to improve automation, tailor experiences, and boost efficiency within its AI-driven mortgage platform.
The company anticipates $400 million in cost savings by streamlining operations and reducing corporate expenses.
Upon closing, Mr. Cooper&#8217;s Chairman and CEO, Jay Bray, will transition to the role of President and CEO of Rocket Mortgage, reporting to Rocket&#8217;s leadership.
Rocket <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n44024705/rocket-companies-announces-fourth-quarter-and-full-year-2024-results" rel="noreferrer noopener">held $1.3 billion in cash and equivalents </a>as of December 31, 2024.
The transaction has been unanimously approved by both companies&#8217; boards and is expected to close in fourth-quarter 2025, pending regulatory approvals and shareholder consent.
Price Action: RKT shares traded lower by 9.40% at $11.81, while COOP is up 14.4% at $119.50 at last check Monday.
Image via Shutterstock.

Equities

COOP

RDFN

Rocket Fuels Mortgage Empire With $9.4 Billion Mr. Cooper Acquisition—One In Six US Mortgages Now Under Its Roof

CNBC Halftime Report Final Trades: Lockheed Martin, Exxon Mobil

In the current session, the stock is trading at $265.21, after a 0.11% increase. Over the past month, T-Mobile US Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) stock increased by 0.12%, and in the past year, by 63.48%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1743440418_0.png" alt="Past Year Chart" />

<h3>T-Mobile US P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 23.28 in the Wireless Telecommunication Services industry, T-Mobile US Inc. has a higher P/E ratio of 27.43. Shareholders might be inclined to think that T-Mobile US Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743440418_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

TMUS

A Look Into T-Mobile US Inc's Price Over Earnings

Leading artificial intelligence chip maker <a href="https://www.benzinga.com/markets/equities/25/03/44445158/nvidias-4-trillion-ambitions-could-drive-the-stock-to-new-frontiers-in-2025">Nvidia</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) plans to invest hundreds of billions of dollars in the U.S. supply chain over the next four years. CEO <a href="https://www.benzinga.com/tech/25/03/44450770/nvidia-ceo-jensen-huangs-joke-sparks-concerns-over-rapid-depreciation-of-ai-chips">Jensen Huang</a> told the<a href="https://www.ft.com/content/3fd3a717-2fbf-42ef-bb08-5baecdeb1985"> Financial Times</a> that the increased U.S. production was being made possible thanks to suppliers such as the <a href="https://www.benzinga.com/25/03/44453733/apples-iphone-18-to-get-massive-boost-with-2nm-a20-chiptsmcs-yields-surge-past-70-says-top-analyst">Taiwan Semiconductor Manufacturing Company </a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NASDAQ">TSM</a>) and Foxconn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FXCOF#NASDAQ">FXCOF</a>).
&#8220;Overall, we will procure, over the course of the next four years, probably half a trillion dollars worth of electronics in total,&#8221; Huang told the FT. &#8220;And I think we can easily see ourselves manufacturing several hundred billion of it here in the U.S.&#8221;
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/startengine-own">The $1.3 billion startup investment boom: How this company's explosive growth is opening doors for everyday investors with a new $500 minimum</a></li>
<li>This platform is reshaping how you invest in private companies —<a href="https://www.benzinga.com/money/kingscrowd-adv"> and you can be a part of it for $0.18 per share</a></li>
</ul>
<h2 class="wp-block-heading">Available Energy: A Crucial Factor</h2>
Huang, speaking on March 18 during his company&#8217;s <a href="https://www.nvidia.com/gtc/keynote/">GTC convention</a>, believed the Trump administration&#8217;s &#8220;America First&#8221; policy would enable his company to ramp up chip production in the U.S.&nbsp;
&#8220;Having the support of an administration who cares about the success of this industry and not allowing energy to be an obstacle is a phenomenal result for AI in the U.S.,&#8221; he told the FT.
<h2 class="wp-block-heading">Nvidia Part Of A U.S. Onshore Tech Explosion</h2>
Huang&#8217;s sentiments follow pledges by other tech companies to onshore manufacturing in the U.S. rather than overseas. Apple has committed to spending<a href="https://www.apple.com/newsroom/2025/02/apple-will-spend-more-than-500-billion-usd-in-the-us-over-the-next-four-years/"> $500 billion</a> in the U.S. over the next four years, expanding teams and facilities in Michigan, Texas, California, Arizona, Nevada, Iowa, Oregon, North Carolina, and Washington.&nbsp;
Trending: <a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a>
TSMC has already committed a $100 billion investment in a chip fabrication plant in Arizona, which<a href="https://www.whitehouse.gov/articles/2025/03/another-historic-investment-secured-under-president-trump/#:~:text=Secretary%20of%20Commerce%20Howard%20Lutnick,with%20a%20$100%20billion%20investment.%E2%80%9D"> President Donald Trump</a> has said would create thousands of jobs bringing Taiwan Semiconductor&#8217;s investment to "about $165 billion."
&#8220;TSMC investing in the U.S. provides for a substantial step up in our supply chain resilience,&#8221; Huang told the FT.&nbsp;
<h2 class="wp-block-heading">Pledging To Build In The U.S.: A Hedge Against Tariffs</h2>
TSMC&#8217;s Taiwan-based production facilities have been an increasingly pivotal part of Nvidia and Apple&#8217;s manufacturing process, which Trump was once keen to change, previously threatening to<a href="https://foreignpolicy.com/2025/02/24/taiwan-tsmc-trump-semiconductors-chips-technology-intel/"> impose tariffs on Taiwan</a>. By pledging to build new facilities in the U.S., Trump said that Taiwan<a href="https://www.theguardian.com/business/2025/mar/04/taiwan-trump-semiconductor-deal-tsmc"> avoided a 25% tariff</a>.&nbsp;
&#8220;TSMC already has plants in the US and Japan, and it&#8217;s now building a new plant in Germany,&#8221;&nbsp; Taiwanese presidential office spokesperson Karen Kuo told the<a href="https://www.theguardian.com/business/2025/mar/04/taiwan-trump-semiconductor-deal-tsmc"> Guardian</a>. &#8220;These have nothing to do with tariffs. TSMC&#8217;s global expansion is a crucial development.&#8221;
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.
<h2 class="wp-block-heading">Data Center Revolution Amid AI Arms Race</h2>
Trump has been basking in a wave of tech commitments to manufacture products in the U.S.
&#8220;GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) announced on Tuesday a nearly $1 billion investment in U.S. manufacturing, the latest company to do so under the Trump administration… It marks the latest company to put money back into the U.S. economy,&#8221; Trump said.&nbsp;
Other tech companies or those that finance them have also announced big U.S.-based investments. Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has announced a<a href="https://www.nytimes.com/2025/01/24/technology/meta-data-center.html"> $65 billion investment</a>, most of which will be used to construct new data centers to fuel its AI operations. This follows investments from Google, Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) in data centers as the AI arms race heats up.&nbsp;
Trump has announced a joint venture between OpenAI, SoftBank, and Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) called<a href="https://www.nytimes.com/2025/01/21/technology/trump-openai-stargate-artificial-intelligence.html"> Stargate</a>, which aims to invest at least<a href="https://www.nytimes.com/2025/01/21/technology/trump-openai-stargate-artificial-intelligence.html"> $100 billion in U.S. data centers</a>. Many of these data centers will house the incredibly powerful GPU computers powering the AI revolution. Nvidia currently has between <a href="https://www.cnbc.com/2024/06/02/nvidia-dominates-the-ai-chip-market-but-theres-rising-competition-.html">70% and 95%</a> of the AI chip market used in GPUs.
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

AMZN

FXCOF

MSFT

NVDA

ORCL

Nvidia To Invest Billions In U.S. Supply Chain As Tech Companies Commit To Trump's Onshoring Pledge

Truist Securities analyst Joon Lee maintains Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) with a Buy and raises the price target from $76 to $150.

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Corcept Therapeutics, Raises Price Target to $150

Financial giants have made a conspicuous bullish move on Corcept Therapeutics. Our analysis of options history for Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) revealed 38 unusual trades.
Delving into the details, we found 42% of traders were bullish, while 34% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $282,776, and 34 were calls, valued at $3,592,834.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $20.0 and $110.0 for Corcept Therapeutics, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Corcept Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Corcept Therapeutics's significant trades, within a strike price range of $20.0 to $110.0, over the past month.
<h3>Corcept Therapeutics Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743439542_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CORT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$22.9</td>
<td>$20.2</td>
<td>$20.6</td>
<td>$95.00</td>
<td>$412.0K</td>
<td align="right">0</td>
<td align="right">201</td>
</tr>
<tr>
<td>CORT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$34.3</td>
<td>$31.3</td>
<td>$32.7</td>
<td>$90.00</td>
<td>$317.1K</td>
<td align="right">726</td>
<td align="right">200</td>
</tr>
<tr>
<td>CORT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$32.5</td>
<td>$31.5</td>
<td>$31.5</td>
<td>$90.00</td>
<td>$315.0K</td>
<td align="right">726</td>
<td align="right">300</td>
</tr>
<tr>
<td>CORT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$31.7</td>
<td>$28.3</td>
<td>$28.3</td>
<td>$90.00</td>
<td>$283.0K</td>
<td align="right">726</td>
<td align="right">100</td>
</tr>
<tr>
<td>CORT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$24.3</td>
<td>$22.0</td>
<td>$22.32</td>
<td>$100.00</td>
<td>$220.6K</td>
<td align="right">91</td>
<td align="right">40</td>
</tr>
</tbody>
</table>

<h3>About Corcept Therapeutics</h3>
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
After a thorough review of the options trading surrounding Corcept Therapeutics, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Corcept Therapeutics</h3>
<ul>
<li>With a trading volume of 8,640,882, the price of CORT is up by 85.93%, reaching $101.57.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 30 days from now.</li>
</ul>
<h3>What The Experts Say On Corcept Therapeutics</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $150.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from HC Wainwright &amp; Co. continues to hold a Buy rating for Corcept Therapeutics, targeting a price of $150. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Corcept Therapeutics, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Corcept Therapeutics's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bullish stance on Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with OXY, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Occidental Petroleum.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 33%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $344,322, and 6 are calls, for a total amount of $288,910.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $75.0 for Occidental Petroleum over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Occidental Petroleum's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Occidental Petroleum's significant trades, within a strike price range of $40.0 to $75.0, over the past month.
<h3>Occidental Petroleum Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743439537_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$2.83</td>
<td>$2.75</td>
<td>$2.83</td>
<td>$42.50</td>
<td>$174.3K</td>
<td>2.9K</td>
<td align="right">616</td>
</tr>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$2.17</td>
<td>$2.09</td>
<td>$2.17</td>
<td>$40.00</td>
<td>$142.7K</td>
<td>829</td>
<td align="right">658</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$2.14</td>
<td>$2.07</td>
<td>$2.14</td>
<td>$65.00</td>
<td>$86.2K</td>
<td>176</td>
<td align="right">403</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$6.05</td>
<td>$6.0</td>
<td>$6.05</td>
<td>$50.00</td>
<td>$60.5K</td>
<td>1.3K</td>
<td align="right">101</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.25</td>
<td>$52.50</td>
<td>$45.9K</td>
<td>5.8K</td>
<td align="right">123</td>
</tr>
</tbody>
</table>

<h3>About Occidental Petroleum</h3>
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,327 thousand barrels of oil equivalent per day in 2024 at a ratio of roughly 50% oil and natural gas liquids and 50% natural gas.
Having examined the options trading patterns of Occidental Petroleum, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Occidental Petroleum</h3>
<ul>
<li>With a volume of 3,998,828, the price of OXY is up 1.33% at $49.48. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 36 days.</li>
</ul>
<h3>Expert Opinions on Occidental Petroleum</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $55.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan persists with their Neutral rating on Occidental Petroleum, maintaining a target price of $52. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Neutral rating on Occidental Petroleum with a target price of $50. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Occidental Petroleum, targeting a price of $58. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on Occidental Petroleum, maintaining a target price of $51. 
&#x2A; An analyst from Raymond James has revised its rating downward to Outperform, adjusting the price target to $64. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Occidental Petroleum with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Occidental Petroleum's Options Frenzy: What You Need to Know

Financial giants have made a conspicuous bullish move on United States Steel. Our analysis of options history for United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) revealed 16 unusual trades.
Delving into the details, we found 43% of traders were bullish, while 31% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $408,964, and 9 were calls, valued at $310,980.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $39.0 to $52.5 for United States Steel over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in United States Steel's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to United States Steel's substantial trades, within a strike price spectrum from $39.0 to $52.5 over the preceding 30 days.
<h3>United States Steel Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743439532_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.3</td>
<td>$12.1</td>
<td>$12.1</td>
<td>$52.50</td>
<td>$79.8K</td>
<td align="right">148</td>
<td align="right">66</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$12.35</td>
<td>$12.0</td>
<td>$12.0</td>
<td>$52.50</td>
<td>$79.2K</td>
<td align="right">148</td>
<td align="right">132</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$5.3</td>
<td>$5.15</td>
<td>$5.3</td>
<td>$43.00</td>
<td>$57.7K</td>
<td align="right">25</td>
<td align="right">109</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.9</td>
<td>$10.5</td>
<td>$10.5</td>
<td>$50.00</td>
<td>$57.7K</td>
<td align="right">695</td>
<td align="right">55</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$10.65</td>
<td>$10.4</td>
<td>$10.4</td>
<td>$50.00</td>
<td>$57.2K</td>
<td align="right">695</td>
<td align="right">110</td>
</tr>
</tbody>
</table>

<h3>About United States Steel</h3>
United States Steel Corp operates in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.
<h3>Present Market Standing of United States Steel</h3>
<ul>
<li>Trading volume stands at 2,005,917, with X's price down by -3.02%, positioned at $41.7.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 31 days.</li>
</ul>
<h3>What Analysts Are Saying About United States Steel</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $44.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from BMO Capital persists with their Outperform rating on United States Steel, maintaining a target price of $45. 
&#x2A; Reflecting concerns, an analyst from BMO Capital lowers its rating to Market Perform with a new price target of $45. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on United States Steel, maintaining a target price of $43. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on United States Steel, which currently sits at a price target of $43. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for United States Steel with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Unpacking the Latest Options Trading Trends in United States Steel

Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) has outperformed the market over the past 5 years by 26.96% on an annualized basis producing an average annual return of 44.4%. Currently, Tapestry has a market capitalization of $15.96 billion. 
Buying $1000 In TPR: If an investor had bought $1000 of TPR stock 5 years ago, it would be worth $6,323.34 today based on a price of $68.50 for TPR at the time of writing.
<h3>Tapestry's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743439516_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Press Releases

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Allurion Relaunches in France

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion to Participate in Upcoming Investor Conferences

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Comments

Allurion Technologies

ニュース

パートナーシップ

ベンジンガ・グローバル